Published in Inflamm Bowel Dis on March 01, 2014
Optimizing the Care and Health of Women with Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.81
Peripheral blood methylation profiling of female Crohn's disease patients. Clin Epigenetics (2016) 0.77
Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry. Inflamm Bowel Dis (2016) 0.75
A simple clinical colitis activity index. Gut (1998) 4.35
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Variation of the human menstrual cycle through reproductive life. Int J Fertil (1970) 4.26
Management of Crohn's disease in adults. Am J Gastroenterol (2009) 3.94
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (2004) 3.63
Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause (2000) 1.93
Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am (1999) 1.67
Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet (1997) 1.61
The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol (1998) 1.35
Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology (1990) 1.31
Association of asthma and hay fever with irregular menstruation. Thorax (2005) 1.25
Menstrual-related problems and psychological distress among women in the United States. J Womens Health (Larchmt) (2005) 1.19
Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol (1976) 1.09
Measuring Crohn's disease activity. Lancet (1980) 1.09
The menopausal transition. Baillieres Clin Obstet Gynaecol (1996) 0.98
ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol (2006) 0.96
Menstrual disorders. Endocr Dev (2012) 0.93
Anovulation. BMJ (2003) 0.93
Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus (2002) 0.92
Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk J Gastroenterol (2003) 0.89
Perceived stress and severity of perimenstrual symptoms: the BioCycle Study. J Womens Health (Larchmt) (2010) 0.88
Gastrointestinal symptoms before and during menses in women with IBD. Aliment Pharmacol Ther (2012) 0.86
Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies. Expert Opin Pharmacother (2012) 0.84
Menstrual disorders in women with epilepsy. Neurology (2006) 0.83
Menstrual disorders in the college age female. Pediatr Clin North Am (2005) 0.83
Gynecologic history of women with inflammatory bowel disease. Obstet Gynecol (1995) 0.82
Dysmenorrhea in women with Crohn's disease: a case-control study. Inflamm Bowel Dis (2013) 0.82
Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus (2009) 0.81
The structured menstrual history: developing a tool to facilitate diagnosis and aid in symptom management. Semin Reprod Med (2011) 0.78
Menstruation and its disorders in adolescence. Curr Probl Pediatr (1982) 0.77
Inflammatory Bowel Disease--A Complicating Factor in Gynecologic Disorders? Medscape Womens Health (1997) 0.77
Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med (2005) 14.50
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med (2013) 4.75
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med (2012) 4.41
Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med (2013) 3.98
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology (2009) 3.73
Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol (2006) 2.97
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology (2011) 2.96
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol (2009) 2.72
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology (2007) 2.55
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology (2005) 2.05
Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev (2005) 2.00
Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension (2009) 1.88
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut (2011) 1.80
Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology (2009) 1.74
The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol (2008) 1.74
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology (2007) 1.71
Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis (2004) 1.65
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology (2007) 1.60
Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.58
Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology (2008) 1.56
Women's health training in gastroenterology fellowship: a national survey of fellows and program directors. Dig Dis Sci (2011) 1.53
Exercise capacity and cardiovascular/metabolic characteristics of overweight and obese individuals with type 2 diabetes: the Look AHEAD clinical trial. Diabetes Care (2007) 1.50
Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease. Inflamm Bowel Dis (2010) 1.42
Alcohol-impaired driving among U.S. adults, 1993-2002. Am J Prev Med (2005) 1.33
Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr (2010) 1.30
Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol (2003) 1.29
Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol (2004) 1.25
Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies. Inflamm Bowel Dis (2011) 1.22
Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr (2009) 1.22
A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease. Am J Gastroenterol (2012) 1.22
Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease. Am J Gastroenterol (2006) 1.21
The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol (2010) 1.19
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflamm Bowel Dis (2010) 1.15
Abatacept for Crohn's disease and ulcerative colitis. Gastroenterology (2012) 1.15
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis (2011) 1.14
Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology (2013) 1.14
Are adult patients more tolerant of treatment risks than parents of juvenile patients? Risk Anal (2008) 1.13
Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.13
Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management. J Manag Care Pharm (2010) 1.11
Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance. J Clin Endocrinol Metab (2008) 1.10
Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg (2008) 1.09
Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology (2010) 1.07
Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis (2006) 1.05
Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation. J Biol Chem (2013) 1.01
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials? Inflamm Bowel Dis (2012) 1.00
Acute appendicitis following colonoscopy. J Clin Gastroenterol (2005) 1.00
Risk factors for colon ischemia. Am J Gastroenterol (2004) 1.00
A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2006) 0.99
State of the art: IBD therapy and clinical trials in IBD. Inflamm Bowel Dis (2005) 0.98
Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut (2011) 0.97
A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol (2013) 0.96
The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut (2007) 0.96
Ordered Ag/Si nanowires array: wide-range surface-enhanced Raman spectroscopy for reproducible biomolecule detection. Nano Lett (2013) 0.93
When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis (2010) 0.93
Selective leukocyte apheresis for the treatment of inflammatory bowel disease. J Clin Gastroenterol (2007) 0.92
Incidence of colonic ischemia, hospitalized complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride. Am J Gastroenterol (2003) 0.92
Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species. Antimicrob Agents Chemother (2003) 0.92
Incarcerated inguinal hernia as the presenting feature of carcinoma of unknown primary site. Med Health R I (2008) 0.91
MR enterography correlates highly with colonoscopy and histology for both distal ileal and colonic Crohn's disease in 310 patients. Eur J Radiol (2012) 0.90
Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Inflamm Bowel Dis (2011) 0.89
Surveillance for certain health behaviors among states and selected local areas--Behavioral Risk Factor Surveillance System, United States, 2003. MMWR Surveill Summ (2005) 0.89
OSCCAR: Ocean State Crohn's and Colitis Area Registry. Med Health R I (2009) 0.89
Sigmoid volvulus in three college-age teenagers. J Clin Gastroenterol (2004) 0.88
Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. J Crohns Colitis (2013) 0.86
Adverse events do not outweigh benefits of combination therapy for Crohn's disease in a decision analytic model. Clin Gastroenterol Hepatol (2011) 0.85
Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire. Inflamm Bowel Dis (2009) 0.85
Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease. Inflamm Bowel Dis (2004) 0.85
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease. Am J Gastroenterol (2008) 0.85
Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genet Med (2005) 0.85
Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection. J Innate Immun (2010) 0.84
Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors. Scand J Gastroenterol (2015) 0.84
Meckel diverticulum: a geriatric disease masquerading as common gastrointestinal tract disorders. Arch Intern Med (2003) 0.83
Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis (2014) 0.83
Efficacy of methotrexate in ulcerative colitis: failure or promise. Inflamm Bowel Dis (2010) 0.83
Effects of growth hormone secretion on body composition in patients with Crohn's disease. J Clin Endocrinol Metab (2003) 0.82
Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn's disease? Surgery (2011) 0.81
Ingested foreign body in the sigmoid colon: detection and localization by CT colonography. Med Health R I (2012) 0.81
Meeting the need for women's health training in gastroenterology: creation of a women's digestive disorders program at Brown University. J Womens Health (Larchmt) (2010) 0.81
Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study. Inflamm Bowel Dis (2015) 0.80
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis (2013) 0.80
Genetics, Genetic Testing, and Biomarkers of Digestive Diseases. Gastroenterology (2015) 0.80
Psychological distress and impaired quality of life common among community-dwelling adults with lower gastrointestinal disorders. Dig Dis Sci (2006) 0.78
Reproductive issues in inflammatory bowel disease. Med Health R I (2009) 0.78
Testing for Clostridium difficile in patients newly diagnosed with inflammatory bowel disease in a community setting. Inflamm Bowel Dis (2015) 0.78